Compare CELU & ZEPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CELU | ZEPP |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3M | 71.9M |
| IPO Year | 2019 | 2017 |
| Metric | CELU | ZEPP |
|---|---|---|
| Price | $0.70 | $5.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 35.0K | ★ 35.4K |
| Earning Date | 05-11-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $26,550,000.00 | N/A |
| Revenue This Year | N/A | $778.34 |
| Revenue Next Year | $76.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.56 | $3.85 |
| 52 Week High | $4.30 | $61.50 |
| Indicator | CELU | ZEPP |
|---|---|---|
| Relative Strength Index (RSI) | 49.43 | 58.81 |
| Support Level | $0.69 | $4.04 |
| Resistance Level | $0.85 | $5.63 |
| Average True Range (ATR) | 0.06 | 0.37 |
| MACD | 0.00 | 0.16 |
| Stochastic Oscillator | 63.16 | 85.80 |
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.